Registry collects health records of people with multiple sclerosis
Gathers electronic health records from people with multiple sclerosis across several care providers.
Key facts
- Who runs it
- The University of Texas Health Science Center, Houston
- Where
- Austin, Cherry Hill, and Houston, United StatesSee the 3 sites
- Trial code
- Registry title
- Multiple Sclerosis Implementation Network (Registry)
- Status
- Recruiting
- People taking part
- 2,000 people, planned
- Started
- 28 Apr 2025
- Expected to end
- 31 Dec 2030
- Type of study
- Observational
- Record updated
- 17 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The registry is looking for adults who have been diagnosed with multiple sclerosis and who speak and understand English comfortably.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Diagnosed with multiple sclerosis. No particular stage or type is named.
Main reasons for not taking part
- Cannot speak and understand English comfortably
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- diagnosed with Multiple Sclerosis
- can speak and understand English comfortably
Where in United States
- The University of Texas at AustinAustin, United StatesContact: Leorah Freeman, MD, PhDTaking people
- Multiple Sclerosis Association of AmericaCherry Hill, United StatesContact: Amanda Mantague, Ed.M.Taking people
- The University of Texas Health Science Center at Houston (UTHealth Houston)Houston, United StatesContact: Maria E. Fernandez, PhDTaking people
About the trial
What the trial wants to find out
The Multiple Sclerosis Implementation Network (MSIN) is a collaboration between the Multiple Sclerosis Association of America (MSAA), The University of Texas Health Science Center at Houston (UTHealth Houston), Dell Medical School at The University of Texas at Austin, and Novartis Pharmaceuticals Corporation. The goal of MSIN is to improve Multiple Sclerosis (MS) care, patient health, and quality of life through the development and support of implementation research and clinical practice collaboration. MSIN brings together healthcare teams, people with MS, and research leaders in MS and implementation science (IS) to learn, share, test, implement, and disseminate innovations that improve MS care, patient health, and quality of life.
Read full original descriptionShow less
This ClinicalTrials.gov record pertains to the MSIN Patient Registry, which is a comprehensive database that integrates participants' electronic health records from various providers.
The group in the trial
- Patients with Multiple Sclerosis
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Multiple Sclerosis Implementation Network
- Plain-language title
- Registry collects health records of people with multiple sclerosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 17 February 2026